MENU
BLSM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BlossomHill Therapeutics (BLSM) Ownership - Who owns BlossomHill Therapeutics?

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment... Show more

Profile

Industry
N/A
Address
10255 Science Center Drive
Phone
+1 858 732-3880
Employees
63
Web
https://www.bhtherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
483.45M
P/E Ratio
-5.71
Total Cash
95.38M
Projected Growth
N/A
Total Debt
23.37M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
10255 Science Center Drive
Phone
+1 858 732-3880
Employees
63
Web
https://www.bhtherapeutics.com
Who owns BlossomHill Therapeutics? BLSM symbol Ownership - Tickeron.com